These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34796642)

  • 21. Potent Tau Aggregation Inhibitor D-Peptides Selected against Tau-Repeat 2 Using Mirror Image Phage Display.
    Malhis M; Kaniyappan S; Aillaud I; Chandupatla RR; Ramirez LM; Zweckstetter M; Horn AHC; Mandelkow E; Sticht H; Funke SA
    Chembiochem; 2021 Nov; 22(21):3049-3059. PubMed ID: 34375027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Site-directed double monoubiquitination of the repeat domain of the amyloid-forming protein tau impairs self-assembly and coacervation.
    Trivellato D; Floriani F; Barracchia CG; Munari F; D'Onofrio M; Assfalg M
    Bioorg Chem; 2023 Mar; 132():106347. PubMed ID: 36630781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Phosphorylation and O-GlcNAcylation on Proline-Rich Domains of Tau.
    Rani L; Mittal J; Mallajosyula SS
    J Phys Chem B; 2020 Mar; 124(10):1909-1918. PubMed ID: 32065850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human Polymerase δ-Interacting Protein 2 (PolDIP2) Inhibits the Formation of Human Tau Oligomers and Fibrils.
    Kasho K; Krasauskas L; Smirnovas V; Stojkovič G; Morozova-Roche LA; Wanrooij S
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-translational modifications of tau protein: implications for Alzheimer's disease.
    Martin L; Latypova X; Terro F
    Neurochem Int; 2011 Mar; 58(4):458-71. PubMed ID: 21215781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrinsic Tau Acetylation Is Coupled to Auto-Proteolytic Tau Fragmentation.
    Cohen TJ; Constance BH; Hwang AW; James M; Yuan CX
    PLoS One; 2016; 11(7):e0158470. PubMed ID: 27383765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unraveling the Influence of K280 Acetylation on the Conformational Features of Tau Core Fragment: A Molecular Dynamics Simulation Study.
    Zou Y; Guan L
    Front Mol Biosci; 2021; 8():801577. PubMed ID: 34966788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
    Stancu IC; Ferraiolo M; Terwel D; Dewachter I
    Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The trans isomer of Tau peptide is prone to aggregate, and the WW domain of Pin1 drastically decreases its aggregation.
    Ikura T; Tochio N; Kawasaki R; Matsuzaki M; Narita A; Kikumoto M; Utsunomiya-Tate N; Tate SI; Ito N
    FEBS Lett; 2018 Sep; 592(18):3082-3091. PubMed ID: 30079475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of Post-Translational Modifications on the Structure and Function of Tau Protein.
    Ye H; Han Y; Li P; Su Z; Huang Y
    J Mol Neurosci; 2022 Aug; 72(8):1557-1571. PubMed ID: 35325356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ATP Kinetically Modulates Pathogenic Tau Fibrillations.
    Heo CE; Han JY; Lim S; Lee J; Im D; Lee MJ; Kim YK; Kim HI
    ACS Chem Neurosci; 2020 Oct; 11(19):3144-3152. PubMed ID: 32915536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lysine methylation is an endogenous post-translational modification of tau protein in human brain and a modulator of aggregation propensity.
    Funk KE; Thomas SN; Schafer KN; Cooper GL; Liao Z; Clark DJ; Yang AJ; Kuret J
    Biochem J; 2014 Aug; 462(1):77-88. PubMed ID: 24869773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural impact of heparin binding to full-length Tau as studied by NMR spectroscopy.
    Sibille N; Sillen A; Leroy A; Wieruszeski JM; Mulloy B; Landrieu I; Lippens G
    Biochemistry; 2006 Oct; 45(41):12560-72. PubMed ID: 17029411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Global Conformation of Tau Protein Mapped by Raman Spectroscopy.
    Gorantla NV; Khandelwal P; Poddar P; Chinnathambi S
    Methods Mol Biol; 2017; 1523():21-31. PubMed ID: 27975242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cryptic Sites in Tau Fibrils Explain the Preferential Binding of the AV-1451 PET Tracer toward Alzheimer's Tauopathy.
    Murugan NA; Nordberg A; Ågren H
    ACS Chem Neurosci; 2021 Jul; 12(13):2437-2447. PubMed ID: 34152739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The acetylation of tau inhibits its function and promotes pathological tau aggregation.
    Cohen TJ; Guo JL; Hurtado DE; Kwong LK; Mills IP; Trojanowski JQ; Lee VM
    Nat Commun; 2011; 2():252. PubMed ID: 21427723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crosstalk between tau protein autoproteolysis and amyloid fibril formation.
    Ashrafi-Kooshk MR; Norouzi F; Zare Karizak A; Ahmadian S; Moosavi-Movahedi AA; Riazi G
    Int J Biol Macromol; 2024 Mar; 262(Pt 2):129953. PubMed ID: 38325678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer's Disease.
    Wesseling H; Mair W; Kumar M; Schlaffner CN; Tang S; Beerepoot P; Fatou B; Guise AJ; Cheng L; Takeda S; Muntel J; Rotunno MS; Dujardin S; Davies P; Kosik KS; Miller BL; Berretta S; Hedreen JC; Grinberg LT; Seeley WW; Hyman BT; Steen H; Steen JA
    Cell; 2020 Dec; 183(6):1699-1713.e13. PubMed ID: 33188775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of Alzheimer's disease amyloid beta peptide fragment 25-35 with tau protein, and with a tau peptide containing the microtubule binding domain.
    Pérez M; Cuadros R; Benítez MJ; Jiménez JS
    J Alzheimers Dis; 2004 Oct; 6(5):461-7. PubMed ID: 15505366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tauopathy: A common mechanism for neurodegeneration and brain aging.
    Saha P; Sen N
    Mech Ageing Dev; 2019 Mar; 178():72-79. PubMed ID: 30668956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.